Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaine.

Kozikowski AP, Johnson KM, Deschaux O, Bandyopadhyay BC, Araldi GL, Carmona G, Munzar P, Smith MP, Balster RL, Beardsley PM, Tella SR.

J Pharmacol Exp Ther. 2003 Apr;305(1):143-50.

2.

Reinforcing strength of a novel dopamine transporter ligand: pharmacodynamic and pharmacokinetic mechanisms.

Woolverton WL, Ranaldi R, Wang Z, Ordway GA, Paul IA, Petukhov P, Kozikowski A.

J Pharmacol Exp Ther. 2002 Oct;303(1):211-7.

3.

Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine.

Katz JL, Izenwasser S, Kline RH, Allen AC, Newman AH.

J Pharmacol Exp Ther. 1999 Jan;288(1):302-15.

4.

Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.

Katz JL, Kopajtic TA, Agoston GE, Newman AH.

J Pharmacol Exp Ther. 2004 May;309(2):650-60. Epub 2004 Jan 30.

5.

Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-administration after oral administration.

Carroll FI, Fox BS, Kuhar MJ, Howard JL, Pollard GT, Schenk S.

Eur J Pharmacol. 2006 Dec 28;553(1-3):149-56. Epub 2006 Sep 23.

PMID:
17067572
6.

Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.

Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL.

J Med Chem. 2004 Dec 2;47(25):6401-9.

PMID:
15566309
7.
8.
9.

Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.

Rothman RB, Blough BE, Woolverton WL, Anderson KG, Negus SS, Mello NK, Roth BL, Baumann MH.

J Pharmacol Exp Ther. 2005 Jun;313(3):1361-9. Epub 2005 Mar 10.

11.
12.

Place conditioning and locomotor effects of N-substituted, 4',4''-difluorobenztropine analogs in rats.

Li SM, Newman AH, Katz JL.

J Pharmacol Exp Ther. 2005 Jun;313(3):1223-30. Epub 2005 Mar 2.

13.

Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.

Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):157-71.

PMID:
14687870
14.

Effect of HD-23, a potent long acting cocaine-analog, on cocaine self-administration in rats.

Roberts DC, Jungersmith KR, Phelan R, Gregg TM, Davies HM.

Psychopharmacology (Berl). 2003 Jun;167(4):386-92. Epub 2003 Apr 1.

PMID:
12669183
15.
17.

Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.

Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, Rice KC, Howell LL.

J Pharmacol Exp Ther. 2004 Jun;309(3):959-69. Epub 2004 Feb 24.

18.

Cocaine-induced locomotor activity and cocaine discrimination in dopamine D4 receptor mutant mice.

Katz JL, Chausmer AL, Elmer GI, Rubinstein M, Low MJ, Grandy DK.

Psychopharmacology (Berl). 2003 Oct;170(1):108-14. Epub 2003 May 29.

PMID:
12783155
19.
20.

Locomotor and discriminative-stimulus effects of cocaine in dopamine D5 receptor knockout mice.

Elliot EE, Sibley DR, Katz JL.

Psychopharmacology (Berl). 2003 Sep;169(2):161-8. Epub 2003 May 27.

PMID:
12768268

Supplemental Content

Support Center